Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about Windtree Therapeutics Recent news which mentions Windtree Therapeutics Windtree Therapeutics – This Biotech Inks License Deal For Lead Candidate January 29, 2024 Tickers WINT Tags Windtree Therapeutics Benzinga Penny Stocks From Benzinga Windtree Therapeutics (NASDAQ: WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company January 25, 2024 Tickers NEWS WINT Tags Partner Content WINT Market News From Benzinga Up To $138 Million in Milestones, Up To Low Double Digit Royalties: Windtree Announces Agreement To Develop And Commercialize Drug Candidates In Greater China January 17, 2024 Tickers NEWS WINT Tags News Windtree Therapeutics Penny Stocks From Benzinga Windtree Therapeutics Announces Reduction In Arrhythmias In A New Study With Istaroxime And A Pure SERCA2a Activator January 03, 2024 Tickers NEWS WINT Tags Biotech Windtree Therapeutics Benzinga From Benzinga Istaroxime Update: Start Of Patient Dosing In Early Cardiogenic Shock SEISMiC Extension Study In Preparation For Phase 3 Readiness, Topline Data Expected mid-2024 December 18, 2023 Tickers WINT Tags General Market News WINT From Benzinga Windtree Therapeutics (NASDAQ: WINT) Is Developing A Multi-Asset Franchise Of Its Novel SERCA2a Activators In A Multi-Billion Dollar Market August 15, 2023 Tickers WINT Tags Biotech Windtree Therapeutics Penny Stocks From Benzinga How Windtree Therapeutics (NASDAQ: WINT) Is Developing A Multi-Asset Franchise Of Its Novel SERCA2a Activators August 15, 2023 Tickers WINT Tags General Market News Partner Content From Benzinga Windtree Therapeutics' (NASDAQ: WINT) Upcoming Istaroxime Development Milestones And Next Generation Drug Candidates Could Produce New Fast Follow-On Line Of Drugs For Heart Failure July 24, 2023 Tickers WINT Tags Windtree Therapeutics Penny Stocks Benzinga From Benzinga The Acute Hospital Care Market Is Worth Over $3 Trillion, And Windtree Therapeutics Brings A First-In-Class Drug To An Active Segment Of This Market July 17, 2023 Tickers AZN BMY MLYS NVS Tags Penny Stocks BMY AZN From Benzinga Windtree Therapeutics – This Biotech Is Developing Drugs For Patients In Crisis July 14, 2023 Tickers WINT Tags Windtree Therapeutics Benzinga Penny Stocks From Benzinga Medical Management Of Deadly Urgent Cardiogenic Shock Largely Remains A Challenge – Windtree Therapeutics (NASDAQ: WINT) Is Helping Change That July 12, 2023 Tickers BMY NVS WINT Tags Partner Content General Benzinga From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.